Dose-Response Characteristics of Olmesartan Medoxomil and Other Angiotensin Receptor Antagonists

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.7, Iss.5, 2007-01, pp. : 347-356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Protective Effects of Angiotensin II Blockade with Olmesartan Medoxomil on Resistance Vessel Remodeling (The VIOS study): Rationale and Baseline Characteristics

By Smith Ronald D.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 335-342

Adis International

Access to resources Recommend Favorite

Antihypertensive Effects of Olmesartan Compared with Other Angiotensin Receptor Blockers: A Meta-Analysis

By Wang Long

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 5, 2012-10 ,pp. : 335-344

Adis International

Access to resources Recommend Favorite

Comparative Cost Effectiveness of Angiotensin II Receptor Blockers in a US Managed Care Setting: Olmesartan Medoxomil Compared with Losartan, Valsartan, and Irbesartan

By Simons W.R.

PharmacoEconomics, Vol. 21, Iss. 1, 2003-01 ,pp. : 61-74

Adis International

Access to resources Recommend Favorite

Olmesartan Medoxomil

By Warner G.T. Jarvis B.

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1345-1353

Adis International

Access to resources Recommend Favorite

Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension

By Deeks Emma D.

Drugs, Vol. 71, Iss. 2, 2011-01 ,pp. : 209-220

Adis International

Access to resources Recommend Favorite